Showing results (21-30 of 102) with videos related to
Sort By:
Pageof 11
International Immunopharmacology|September 22, 2024
A nomogram for predicting survival based on hemoglobin A1c and circulating tumor cells in advanced gastric cancer patients receiving immunotherapyChenyu Wei, Haolin Sun, Shujing Liu, et al.Scientific Reports|October 21, 2015
Systems assessment of intercalated combination of chemotherapy and EGFR TKIs versus chemotherapy or EGFR TKIs alone in advanced NSCLC patientsHan Yan, Qin Li, Wei Wang, et al.Oncotarget|April 14, 2016
Meta-analysis comparing maintenance strategies with continuous therapy and complete chemotherapy-free interval strategies in the treatment of metastatic colorectal cancerLei Zhao, Jing Wang, Huihui Li, et al.Oncotarget|September 24, 2017
PD-1/PD-L1 antibodies efficacy and safety versus docetaxel monotherapy in advanced NSCLC patients after first-line treatment option: systems assessmentQiang Su, Zhigang Sun, Chenguang Zhang, et al.Journal of Clinical Medicine|April 14, 2026
Navigating Immunotherapy Resistance: The Role of Cross-Line Strategies in Cancer TreatmentYan Kang, Hongchao Zhen, Jing Wang, et al.BMC Cancer|March 29, 2022
Efficacy and safety of adjuvant EGFR-TKIs for resected non-small cell lung cancer: a systematic review and meta-analysis based on randomized control trialsPengfei Zhao, Hongchao Zhen, Hong Zhao, et al.Cancer Biotherapy & Radiopharmaceuticals|June 17, 2017
Molecular Targeted Drugs and Treatment of Colorectal Cancer: Recent Progress and Future PerspectivesFang Geng, Zheng Wang, Hang Yin, et al.Frontiers in Oncology|October 12, 2020
KDM5c Promotes Colon Cancer Cell Proliferation Through the FBXW7-c-Jun Regulatory AxisHaishan Lin, Nina Ma, Lei Zhao, et al.Journal of Translational Medicine|March 6, 2023
Identification of hub genes and potential molecular mechanisms related to radiotherapy sensitivity in rectal cancer based on multiple datasetsPengfei Zhao, Hongchao Zhen, Hong Zhao, et al.BMC Cancer|July 10, 2026
Safety and tolerability of PARP inhibitors in cancer patients: a network meta-analysis of randomized controlled trialsChenyu Wei, Shujing Liu, Jiexuan Hu, et al.Pageof 11